POPULARITY
Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-263 Overview: The FDA's recent emergency use authorization (EUA) for oral agents to treat COVID-19 means that primary care providers (PCPs) will be on the frontline of treating patients with COVID-19. Therefore, PCPs must understand who is eligible for such treatments and how to prescribe them. We will discuss the results of the recent FDA EUA for Pfizer's Paxlovid and Merck's molnupiravir antiviral agents and give you the information you need to confidently prescribe them. Episode resource links: FACT SHEET FOR HEALTHCARE PROVIDERS: EMERGENCY USE AUTHORIZATION FOR MOLNUPIRAVIR (fda.gov) FACT SHEET FOR HEALTHCARE PROVIDERS: EMERGENCY USE AUTHORIZATION FOR PAXLOVID (fda.gov) Guest: Robert A. Baldor MD, FAAFP Music Credit: Richard Onorato
Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-253 Overview: ACE (angiotensin-converting enzyme) inhibitors and ARBs (angiotensin receptor blockers) are both recommended as first-line treatments for hypertension. ACE inhibitors have known side effects, such as cough, that are frustrating for many patients, while ARBs appear to have less annoying side effects. This podcast will review a recently published retrospective, comparative cohort study comparing the effectiveness and safety of ACE inhibitors vs ARBs in the first-line treatment of hypertension. Episode resource links: Hypertension. 2021;78:591–603. DOI: 10.1161/HYPERTENSIONAHA.120.16667 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/ NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol. 2018;71:e127–e248. doi: 10.1016/j.jacc.2017.11.006 Guest: Robert A. Baldor MD, FAAFP Music Credit: Richard Onorato
Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-253 Overview: ACE (angiotensin-converting enzyme) inhibitors and ARBs (angiotensin receptor blockers) are both recommended as first-line treatments for hypertension. ACE inhibitors have known side effects, such as cough, that are frustrating for many patients, while ARBs appear to have less annoying side effects. This podcast will review a recently published retrospective, comparative cohort study comparing the effectiveness and safety of ACE inhibitors vs ARBs in the first-line treatment of hypertension. Episode resource links: Hypertension. 2021;78:591–603. DOI: 10.1161/HYPERTENSIONAHA.120.16667 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/ NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol. 2018;71:e127–e248. doi: 10.1016/j.jacc.2017.11.006 Guest: Robert A. Baldor MD, FAAFP Music Credit: Richard Onorato
Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-250 Overview: While the data conflict on how much sodium intake is optimal for preventing cardiovascular disease, it is clear that daily salt intake for most Americans exceeds what is recommended. However, restricting salt intake on an individual or on a public health level has been controversial. An interesting alternative is the use of salt substitutes, which can help to decrease sodium intake while increasing potassium intake, and both have been associated with lowering blood pressure. Join us to hear a discussion on the results of the recently published studies on salt and cardiovascular disease, along with an overview of the Salt Substitute and Stroke Study (SSaSS). Episode resource links: Neal B, Wu Y, Feng X, et al. Effect of salt substitution on cardiovascular events and death. N Engl J Med. DOI: 10.1056/NEJMoa2105675 O'Donnell M, Mente A, Alderman MH, et al. Salt and cardiovascular disease: insufficient evidence to recommend low sodium intake, European Heart Journal, Volume 41, Issue 35, 14 September 2020, Pages 3363–3373, https://doi.org/10.1093/eurheartj/ehaa586 Circulation. 2021;143:1542–1567. DOI: 10.1161/CIRCULATIONAHA.120.050371 Guest: Robert A. Baldor MD, FAAFP Music Credit: Richard Onorato
Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-250 Overview: While the data conflict on how much sodium intake is optimal for preventing cardiovascular disease, it is clear that daily salt intake for most Americans exceeds what is recommended. However, restricting salt intake on an individual or on a public health level has been controversial. An interesting alternative is the use of salt substitutes, which can help to decrease sodium intake while increasing potassium intake, and both have been associated with lowering blood pressure. Join us to hear a discussion on the results of the recently published studies on salt and cardiovascular disease, along with an overview of the Salt Substitute and Stroke Study (SSaSS). Episode resource links: Neal B, Wu Y, Feng X, et al. Effect of salt substitution on cardiovascular events and death. N Engl J Med. DOI: 10.1056/NEJMoa2105675 O'Donnell M, Mente A, Alderman MH, et al. Salt and cardiovascular disease: insufficient evidence to recommend low sodium intake, European Heart Journal, Volume 41, Issue 35, 14 September 2020, Pages 3363–3373, https://doi.org/10.1093/eurheartj/ehaa586 Circulation. 2021;143:1542–1567. DOI: 10.1161/CIRCULATIONAHA.120.050371 Guest: Robert A. Baldor MD, FAAFP Music Credit: Richard Onorato
Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-238 Overview: Join us to discuss important changes in the 2021 USPSTF recommendation on lung cancer screening. Given lung cancer's high prevalence and poor prognosis in later stages, it is important for primary care clinicians to know which patients to screen and what method to use. You'll also learn the appropriate time to stop screening. Episode resource links: Screening for Lung Cancer US Preventive Services Task Force Recommendation Statement JAMA. 2021;325(10):962-970. doi:10.1001/jama.2021.1117 Guest: Robert A. Baldor MD, FAAFP Music Credit: Richard Onorato
Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-238 Overview: Join us to discuss important changes in the 2021 USPSTF recommendation on lung cancer screening. Given lung cancer's high prevalence and poor prognosis in later stages, it is important for primary care clinicians to know which patients to screen and what method to use. You'll also learn the appropriate time to stop screening. Episode resource links: Screening for Lung Cancer US Preventive Services Task Force Recommendation Statement JAMA. 2021;325(10):962-970. doi:10.1001/jama.2021.1117 Guest: Robert A. Baldor MD, FAAFP Music Credit: Richard Onorato
Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-234 Overview: Many providers overtreat outpatient infections for fear of not treating until resolution or causing a complication, but this can lead to antibiotic resistance and adverse events. Join us to discuss the new ACP guidelines on antibiotic use in the outpatient setting and the pediatric treatment recommendations. Walk away with a clear understanding of the guidelines for optimal duration of antibiotic treatment for individuals with an outpatient infection. Episode resource links: ACP: Ann Intern Med. doi:10.7326/M20-7355; https://www.acpjournals.org/doi/pdf/10.7326/M20-7355 Low risk for PCN allergy: Am J Respir Crit Care Med 2020 Feb 21; [e-pub]. (https://doi.org/10.1164/rccm.202001-0089LE); Mayo Clinic Proceedings 2018, 93 (1): 101-107 Guest: Robert A. Baldor MD, FAAFP Music Credit: Richard Onorato
Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-234 Overview: Many providers overtreat outpatient infections for fear of not treating until resolution or causing a complication, but this can lead to antibiotic resistance and adverse events. Join us to discuss the new ACP guidelines on antibiotic use in the outpatient setting and the pediatric treatment recommendations. Walk away with a clear understanding of the guidelines for optimal duration of antibiotic treatment for individuals with an outpatient infection. Episode resource links: ACP: Ann Intern Med. doi:10.7326/M20-7355; https://www.acpjournals.org/doi/pdf/10.7326/M20-7355 Low risk for PCN allergy: Am J Respir Crit Care Med 2020 Feb 21; [e-pub]. (https://doi.org/10.1164/rccm.202001-0089LE); Mayo Clinic Proceedings 2018, 93 (1): 101-107 Guest: Robert A. Baldor MD, FAAFP Music Credit: Richard Onorato
Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-231 Overview: Who couldn't use a refresher on how to diagnose and treat neck pain in the primary care setting? Review the techniques for assessing neck pain, determining its cause, and providing relief. Immediately apply what you learn to start helping patients with neck pain feel better. Episode resource links: Am Fam Physician 2016 May 1;93(9):746-54. Sub occipital Release: J Electromyogr Kinesiol 2016 Oct;30:31-7. doi: 10.1016/j.jelekin.2016.05.007 Self Myofascial Release: Spine 2020 Nov 1;45(21):E1367-E1375 Guest: Robert A. Baldor MD, FAAFP/Frank Music Credit: Richard Onorato
Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-231 Overview: Who couldn't use a refresher on how to diagnose and treat neck pain in the primary care setting? Review the techniques for assessing neck pain, determining its cause, and providing relief. Immediately apply what you learn to start helping patients with neck pain feel better. Episode resource links: Am Fam Physician 2016 May 1;93(9):746-54. Sub occipital Release: J Electromyogr Kinesiol 2016 Oct;30:31-7. doi: 10.1016/j.jelekin.2016.05.007 Self Myofascial Release: Spine 2020 Nov 1;45(21):E1367-E1375 Guest: Robert A. Baldor MD, FAAFP/Frank Music Credit: Richard Onorato
Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-230 Overview: Join us to discuss the results of the Perioperative Anticoagulation Use for Surgery Evaluation (PAUSE) cohort study, aimed at understanding the safety of using a simplified perioperative management approach for patients with atrial fibrillation taking DOACs. After this episode, you'll be able to make sense of the controversy over current guidelines around surgical care in this patient population. More importantly, you'll walk away with practical knowledge to help these patients minimize their risk of adverse events. Episode resource links: Perioperative Management of Patients With Atrial Fibrillation Receiving a Direct Oral Anticoagulant. JAMA Intern Med.2019; 179(11 ): 1469-14 78. doi: 10.1001 /jamainternmed.2019.2431 Guest: Robert A. Baldor MD, FAAFP Music Credit: Richard Onorato
Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-230 Overview: Join us to discuss the results of the Perioperative Anticoagulation Use for Surgery Evaluation (PAUSE) cohort study, aimed at understanding the safety of using a simplified perioperative management approach for patients with atrial fibrillation taking DOACs. After this episode, you'll be able to make sense of the controversy over current guidelines around surgical care in this patient population. More importantly, you'll walk away with practical knowledge to help these patients minimize their risk of adverse events. Episode resource links: Perioperative Management of Patients With Atrial Fibrillation Receiving a Direct Oral Anticoagulant. JAMA Intern Med.2019; 179(11 ): 1469-14 78. doi: 10.1001 /jamainternmed.2019.2431 Guest: Robert A. Baldor MD, FAAFP Music Credit: Richard Onorato
Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-228 Overview: Join us for this episode as we discuss the results of a systematic review examining the benefits and risks from delaying the use of antibiotics to treat patients in the community for a respiratory infection. Episode resource links: Delayed antibiotic prescribing for respiratory tract infections: individual patient data meta-analysis. BMJ 2021;372:n808 http://dx.doi.org/10.1136/bmj.n808 Guest: Robert A. Baldor, MD, FAAFP Music Credit: Richard Onorato
Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-228 Overview: Join us for this episode as we discuss the results of a systematic review examining the benefits and risks from delaying the use of antibiotics to treat patients in the community for a respiratory infection. Episode resource links: Delayed antibiotic prescribing for respiratory tract infections: individual patient data meta-analysis. BMJ 2021;372:n808 http://dx.doi.org/10.1136/bmj.n808 Guest: Robert A. Baldor, MD, FAAFP Music Credit: Richard Onorato
Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-227 Overview: Join us as we discuss a recent review article on the evidence behind monofilament testing for peripheral neuropathy in people with diabetes. Episode resource links: J Diabetes Res. 2017; 2017: 8787261. Diagnostic Accuracy of Monofilament Tests for Detecting Diabetic Peripheral Neuropathy: A Systematic Review and Meta-Analysis Diabetes Care 2017 Jan;40(1):136-154 Guest: Robert A. Baldor MD, FAAFP Music Credit: Richard Onorato
Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-227 Overview: Join us as we discuss a recent review article on the evidence behind monofilament testing for peripheral neuropathy in people with diabetes. Episode resource links: J Diabetes Res. 2017; 2017: 8787261. Diagnostic Accuracy of Monofilament Tests for Detecting Diabetic Peripheral Neuropathy: A Systematic Review and Meta-Analysis Diabetes Care 2017 Jan;40(1):136-154 Guest: Robert A. Baldor MD, FAAFP Music Credit: Richard Onorato
Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-225 Overview: Join us for this episode as we review the recently published (Dec. 2020) cohort study in JAMA on using bisphosphonates to prevent hip fractures. We will review the utility of bisphosphonates after 5 years and how to discuss their risks and benefits with patients. Episode resource links: JAMA.2020;3(12):e2025190.doi:10.1001/jamanetworkopen.2020.25190 JAMA. 2018;319(24):2521-2531. doi:10.1001/jama.2018.7498 https://www.sheffield.ac.uk/FRAX/tool.aspx?country=9 Guest: Robert A. Baldor MD, FAAFP Music Credit: Richard Onorato
Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-225 Overview: Join us for this episode as we review the recently published (Dec. 2020) cohort study in JAMA on using bisphosphonates to prevent hip fractures. We will review the utility of bisphosphonates after 5 years and how to discuss their risks and benefits with patients. Episode resource links: JAMA.2020;3(12):e2025190.doi:10.1001/jamanetworkopen.2020.25190 JAMA. 2018;319(24):2521-2531. doi:10.1001/jama.2018.7498 https://www.sheffield.ac.uk/FRAX/tool.aspx?country=9 Guest: Robert A. Baldor MD, FAAFP Music Credit: Richard Onorato
Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-222 Overview: Join us for this episode as we discuss a recent Cochrane review of the safety and effectiveness of topical treatments for toenail onychomycosis, and review when and how to prescribe these agents for patients. Episode resource links: Topical and device-based treatments for fungal infections of the toenails. Cochrane Database Syst Rev. 2020; (1): CD012093 Guest: Robert A. Baldor MD, FAAFP Music Credit: Richard Onorato
Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-222 Overview: Join us for this episode as we discuss a recent Cochrane review of the safety and effectiveness of topical treatments for toenail onychomycosis, and review when and how to prescribe these agents for patients. Episode resource links: Topical and device-based treatments for fungal infections of the toenails. Cochrane Database Syst Rev. 2020; (1): CD012093 Guest: Robert A. Baldor MD, FAAFP Music Credit: Richard Onorato
Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-220 Overview: Join us for this episode as we review a recent meta-analysis that addresses best treatment modalities for adhesive capsulitis. Episode resource links: JAMA Netw Open. 2020 Dec 1;3(12):e2029581. Guest: Robert A. Baldor MD, FAAFP Music Credit: Richard Onorato
Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-220 Overview: Join us for this episode as we review a recent meta-analysis that addresses best treatment modalities for adhesive capsulitis. Episode resource links: JAMA Netw Open. 2020 Dec 1;3(12):e2029581. Guest: Robert A. Baldor MD, FAAFP Music Credit: Richard Onorato
Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-218 Overview: Join us for this session where we will discuss the data behind the recent USPSTF recommendations on the use of ASA as a colorectal cancer (CRC) preventive agent, and when to incorporate this recommendation into practice. Episode resource links: www.uspreventiveservicestaskforce.org/uspstf/recommendation/aspirin-to-prevent-cardiovascular-disease-and-cancer doi:10.1001/jamaoncol.2020.7338 N Engl J Med 2018; 379:1519-1528 DOI: 10.1056/NEJMoa1803955 Guest: Robert A. Baldor MD, FAAFP Music Credit: Richard Onorato
Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-218 Overview: Join us for this session where we will discuss the data behind the recent USPSTF recommendations on the use of ASA as a colorectal cancer (CRC) preventive agent, and when to incorporate this recommendation into practice. Episode resource links: www.uspreventiveservicestaskforce.org/uspstf/recommendation/aspirin-to-prevent-cardiovascular-disease-and-cancer doi:10.1001/jamaoncol.2020.7338 N Engl J Med 2018; 379:1519-1528 DOI: 10.1056/NEJMoa1803955 Guest: Robert A. Baldor MD, FAAFP Music Credit: Richard Onorato
Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-210 Overview: This session will review the evidence used by the National Asthma Education and Prevention Program (NAEPP) in making their newer recommendations and the new asthma management protocols. Guest: Robert A. Baldor, MD, FAAFP Music Credit: Richard Onorato
Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-210 Overview: This session will review the evidence used by the National Asthma Education and Prevention Program (NAEPP) in making their newer recommendations and the new asthma management protocols. Guest: Robert A. Baldor, MD, FAAFP Music Credit: Richard Onorato
Credits: 0.25 AMA PRA Category 1 Credits™ Claim CME/CE credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-200 Overview: Join us for the 200th episode of Frankly Speaking about Family Medicine! In this episode, each podcaster will review their favorite topics since the inception of this podcast and will describe patient encounters where this practice changing knowledge was helpful. Guest: Alan Ehrlich, MD, FAAFP; Robert A. Baldor, MD, FAAFP; Susan Feeney, DNP, FNP-BC, NP-C; Jill Terrien, PhD, ANP-BC Music Credit: Richard Onorato
Credits: 0.25 AMA PRA Category 1 Credits™ Claim CME/CE credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-200 Overview: Join us for the 200th episode of Frankly Speaking about Family Medicine! In this episode, each podcaster will review their favorite topics since the inception of this podcast and will describe patient encounters where this practice changing knowledge was helpful. Guest: Alan Ehrlich, MD, FAAFP; Robert A. Baldor, MD, FAAFP; Susan Feeney, DNP, FNP-BC, NP-C; Jill Terrien, PhD, ANP-BC Music Credit: Richard Onorato
Credits: 0.25 AMA PRA Category 1 Credits™ Claim CME/CE credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-192 Overview: Currently a low-dose CT scan is the only screening test for lung cancer that is recommended by the American Cancer Society. In July 202, the U.S. Preventive Services Task Force (USPSTF) issued a draft recommendation statement on screening for lung cancer. The USPSTF suggests annual screening with low-dose CT for individuals aged 50-80 who have a 20 pack-year smoking history and who currently smoke or have quit smoking within the past 15 years. These recommendations expand screening eligibility, but they also suggest that screening be discontinued if a person has not smoked for 15 years, develops a health problem that substantially limits life expectancy, or is unable or unwilling to have curative lung surgery. Guest: Robert A. Baldor, MD, FAAFP Music Credit: Richard Onorato
Credits: 0.25 AMA PRA Category 1 Credits™ Claim CME/CE credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-180 Overview: The American College of Rheumatology (ACR) updated their 2012 guidelines for treating gout. To do this, they used established evidenced-based methods including population, intervention, comparator, outcomes (PICO) questions. Guest: Guest: Robert A. Baldor, MD, FAAFP Music Credit: Richard Onorato
Credits: 0.25 AMA PRA Category 1 Credits™ Claim CME/CE credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-180 Overview: The American College of Rheumatology (ACR) updated their 2012 guidelines for treating gout. To do this, they used established evidenced-based methods including population, intervention, comparator, outcomes (PICO) questions. Guest: Guest: Robert A. Baldor, MD, FAAFP Music Credit: Richard Onorato
Credits: 0.25 AMA PRA Category 1 Credits™ Claim CME/CE credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-178 Overview: As men age, over-active bladder (OAB) symptoms (urgency, frequency, nocturia) are commonly seen. Typically, these symptoms are secondary to the development of benign prostate hypertrophy (BPH). Alpha-blocking and/or antimuscarinic agents are commonly prescribed to treat such symptoms. In this podcast we review the COBALT study which examines the benefits of behavioral treatments (pelvic floor muscle training and fluid restriction before bedtime) alone or combined with drug therapy to treat OAB symptoms. Guest: Robert A. Baldor, MD, FAAFP Music Credit: Richard Onorato
Credits: 0.25 AMA PRA Category 1 Credits™ Claim CME/CE credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-178 Overview: As men age, over-active bladder (OAB) symptoms (urgency, frequency, nocturia) are commonly seen. Typically, these symptoms are secondary to the development of benign prostate hypertrophy (BPH). Alpha-blocking and/or antimuscarinic agents are commonly prescribed to treat such symptoms. In this podcast we review the COBALT study which examines the benefits of behavioral treatments (pelvic floor muscle training and fluid restriction before bedtime) alone or combined with drug therapy to treat OAB symptoms. Guest: Robert A. Baldor, MD, FAAFP Music Credit: Richard Onorato
Credits: 0.25 AMA PRA Category 1 Credits™ Claim CME/CE credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-172 Overview: As men age, over-active bladder (OAB) symptoms (urgency, frequency, nocturia) are commonly seen. Typically, these symptoms are secondary to the development of benign prostate hypertrophy (BPH). Alpha-blocking and/or antimuscarinic agents are commonly prescribed to treat such symptoms. In this podcast we review the COBALT study which examines the benefits of behavioral treatments (pelvic floor muscle training and fluid restriction before bedtime) alone or combined with drug therapy to treat OAB symptoms. Guest: Robert A. Baldor, MD, FAAFP Music Credit: Richard Onorato
Credits: 0.25 AMA PRA Category 1 Credits™ Claim CME/CE credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-172 Overview: As men age, over-active bladder (OAB) symptoms (urgency, frequency, nocturia) are commonly seen. Typically, these symptoms are secondary to the development of benign prostate hypertrophy (BPH). Alpha-blocking and/or antimuscarinic agents are commonly prescribed to treat such symptoms. In this podcast we review the COBALT study which examines the benefits of behavioral treatments (pelvic floor muscle training and fluid restriction before bedtime) alone or combined with drug therapy to treat OAB symptoms. Guest: Robert A. Baldor, MD, FAAFP Music Credit: Richard Onorato
Credits: 0.25 AMA PRA Category 1 Credits™ Claim CME/CE credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-166 Overview: Alcohol consumption has been associated with negative cardiovascular outcomes, yet many clinicians still counsel patients that it is okay in moderation. Past observational studies have supported this idea, showing a dose-dependent relationship between alcohol consumption and the incidence of a-fib. In this episode we will explore the latest RCT out of Australia, which suggest that no level of alcohol intake is safe when it comes to a-fib. Guest: Robert A. Baldor, MD, FAAFP Music Credit: Richard Onorato
Credits: 0.25 AMA PRA Category 1 Credits™ Claim CME/CE credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-166 Overview: Alcohol consumption has been associated with negative cardiovascular outcomes, yet many clinicians still counsel patients that it is okay in moderation. Past observational studies have supported this idea, showing a dose-dependent relationship between alcohol consumption and the incidence of a-fib. In this episode we will explore the latest RCT out of Australia, which suggest that no level of alcohol intake is safe when it comes to a-fib. Guest: Robert A. Baldor, MD, FAAFP Music Credit: Richard Onorato
Credits: 0.25 AMA PRA Category 1 Credits™ Claim CME/CE credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-164 Overview: Review the latest recommendations from the CDC to assist in responding to patient questions and concerns. Guest: Robert A. Baldor, MD, FAAFP Music Credit: Richard Onorato
Credits: 0.25 AMA PRA Category 1 Credits™ Claim CME/CE credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-164 Overview: Review the latest recommendations from the CDC to assist in responding to patient questions and concerns. Guest: Robert A. Baldor, MD, FAAFP Music Credit: Richard Onorato
Credits: 0.25 AMA PRA Category 1 Credits™ Claim CME/CE credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-150 Overview: Join us as we review a landmark paper that reached the conclusion that limiting red meat would not have a large impact on patient outcomes. Guest: Robert A. Baldor, MD, FAAFP Music Credit: Richard Onorato
Credits: 0.25 AMA PRA Category 1 Credits™ Claim CME/CE credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-150 Overview: Join us as we review a landmark paper that reached the conclusion that limiting red meat would not have a large impact on patient outcomes. Guest: Robert A. Baldor, MD, FAAFP Music Credit: Richard Onorato
Credits: 0.25 AMA PRA Category 1 Credits™ Claim CME/CE credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-142 Overview: There has been increasing interest in the use of endovascular reperfusion for patients who have suffered an ischemic stroke. The American Heart Association (AHA) and the American Stroke Association (ASA) have jointly developed a nationwide registry to evaluate the benefits of these techniques on stroke outcomes. During this episode we will review a recent retrospective cohort study of almost 7,000 patients presenting with an acute ischemic stroke that demonstrates a significant benefit to endovascular reperfusion, even several hours after the onset of symptoms. Guest: Robert A. Baldor, MD, FAAFP Music Credit: Richard Onorato
Credits: 0.25 AMA PRA Category 1 Credits™ Claim CME/CE credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-142 Overview: There has been increasing interest in the use of endovascular reperfusion for patients who have suffered an ischemic stroke. The American Heart Association (AHA) and the American Stroke Association (ASA) have jointly developed a nationwide registry to evaluate the benefits of these techniques on stroke outcomes. During this episode we will review a recent retrospective cohort study of almost 7,000 patients presenting with an acute ischemic stroke that demonstrates a significant benefit to endovascular reperfusion, even several hours after the onset of symptoms. Guest: Robert A. Baldor, MD, FAAFP Music Credit: Richard Onorato
Credits: 0.25 AMA PRA Category 1 Credits™ Claim CME/CE credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-140 Overview: This session will discuss the utility of digital apps and daily self-weight measurement for weight loss. Guest: Robert A. Baldor, MD, FAAFP Music Credit: Richard Onorato
Credits: 0.25 AMA PRA Category 1 Credits™ Claim CME/CE credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-140 Overview: This session will discuss the utility of digital apps and daily self-weight measurement for weight loss. Guest: Robert A. Baldor, MD, FAAFP Music Credit: Richard Onorato
Credits: 0.25 AMA PRA Category 1 Credits™ Claim CME/CE credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-137 Overview: In this episode we expand on the rationale for not screening and treating hyperlipidemia in patients without CV disease, diabetes, renal failure or heart failure. Guest: Robert A. Baldor, MD Music Credit: Richard Onorato
Credits: 0.25 AMA PRA Category 1 Credits™ Claim CME/CE credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-137 Overview: In this episode we expand on the rationale for not screening and treating hyperlipidemia in patients without CV disease, diabetes, renal failure or heart failure. Guest: Robert A. Baldor, MD Music Credit: Richard Onorato
Guest: Robert A. Baldor, MD Guest: Chadwick R. Johr, MD This innovative, 45-minute, case-based CME activity features two prominent faculty covering important, timely issues and data related to the detection of autoimmune (AI) disorders. Using case studies, the faculty will explore diagnosis and management strategies to maximize patient care. In addition to the analysis of AI cases, key topics will be covered, including: Evaluation for suspected RA Combination serological assessment 14-3-3eta as a marker for joint damage Autoantibodies in SLE diagnosis and classification ANA IFA and subserologies Diagnosis of RA, Sjögren’s, Lupus, and Systemic Sclerosis
Guest: Robert A. Baldor, MD Guest: Chadwick R. Johr, MD This innovative, 30-minute, online activity features a Video Expert Dialogue with two prominent faculty covering important, timely issues and data related to the detection of autoimmune (AI) disorders. The emphasis is on the unique role primary care providers play in diagnosing and managing AI and maximizing patient care. Topics include: Overview of connective tissue diseases and ANA testing ANA IFA and ELISA New tests Subserologies with IFA Choosing wisely about ANA testing Diagnosis of RA, Sjögren’s, Lupus, and Systemic Sclerosis Titer Information Negative ANA testing When to refer We’ll be discussing autoantibody testing for autoimmune diseases, or more precisely, connective tissue diseases. Our purpose here is to discuss how autoantibody testing, such as the ANA, may be used in the primary care setting to diagnose these disorders. Using the ANA test combined with a good medical exam and a good history, along with signs and symptoms of connective tissue diseases, will help to achieve greater benefits in diagnosing and treating patients.